A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
Phase of Trial: Phase IV
Latest Information Update: 17 Dec 2015
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- Acronyms RECOGNIZE
- 25 Mar 2015 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov
- 19 Aug 2014 Planned End Date changed from 1 Jan 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.
- 19 Aug 2014 Planned primary completion date changed from 1 Jan 2014 to 1 Jan 2015 as reported by ClinicalTrials.gov record.